Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)

Published:2015-02-17 Issue:3 Volume:20 Page:370-378
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Barr Kumarakulasinghe Nesaretnam¹,Zanwijk Nico van²,Soo Ross A.¹³⁴

Affiliation:

1. Department of Haematology-Oncology; National University Cancer Institute, National University Health System; Singapore

2. Asbestos Disease Research Institute; University of Sydney; Concord New South Wales Australia

3. Cancer Science Institute of Singapore; National University of Singapore; Singapore

4. Department of Surgery; University of Western Australia; Perth Western Australia Australia

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12490/fullpdf

Reference87 articles.

1. Howlader N Noone AM Krapcho M Garshell J Miller D Altekruse SF Kosary CL Yu M Ruhl J Tatalovich Z et al SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer http://seer.cancer.gov/statfacts/html/lungb.html

2. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials;NSCLC Meta-Analyses Collaborative Group;J. Clin. Oncol.,2008

3. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N. Engl. J. Med.,2002

4. Cancer. Addiction to oncogenes-the Achilles heal of cancer;Weinstein;Science,2002

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management;Cellular Signalling;2024-01

2. Cell-Surface GRP78-Targeted Chimeric Antigen Receptor T Cells Eliminate Lung Cancer Tumor Xenografts;International Journal of Molecular Sciences;2024-01-01

3. METTL3‐mediated m⁶A methylation of TRAF5 inhibits lung adenocarcinoma cell metastasis via activation of the PI3K/AKT/NF‐κB signaling pathway;The Kaohsiung Journal of Medical Sciences;2023-12-13

4. Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma;BMJ Open Respiratory Research;2023-12

5. Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis;Medicine;2023-11-10